Inventor · disambiguated record
Theresa M. Williams
Also filed as: WILLIAMS THERESA M · WILLIAMS Theresa
59 granted patents·18 pending applications·2,095 citations·filing 1990–2025
99Inventor score
Files withMERCK & CO INC43SHY Therapeutics LLC20MERCK SHARP & DOHME4WILLIAMS THERESA M2ANTHONY NEVILLE J1
Top patents by PatentIndex Score
77 records- 0197US5856326AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted Jan 5, 1999·280 cites·13 claims
- 0297US5756528AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted May 26, 1998·149 cites·21 claims
- 0396US7390798B2Carboxamide spirolactam CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Jun 24, 2008·58 cites·23 claims
- 0496US6248756B1Inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1999·Granted Jun 19, 2001·101 cites·11 claims
- 0595US6080870ABiaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitorsMERCK & CO INC·Filed 1997·Granted Jun 27, 2000·105 cites·36 claims
- 0695US5965578AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Oct 12, 1999·89 cites·20 claims
- 0795US5919785AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jul 6, 1999·134 cites·24 claims
- 0895US5578629ABenzamide-containing inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1995·Granted Nov 26, 1996·100 cites·17 claims
- 0995US5527819AInhibitors of HIV reverse transcriptaseMERCK & CO INC·Filed 1995·Granted Jun 18, 1996·109 cites·9 claims
- 1094US7452903B2CGRP receptor antagonistsMERCK & CO INC·Filed 2007·Granted Nov 18, 2008·22 cites·6 claims
- 1194US7235545B2CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Jun 26, 2007·22 cites·4 claims
- 1293US12168668B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2022·Granted Dec 17, 2024·1 cites·16 claims
- 1393US5977134AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Nov 2, 1999·73 cites·49 claims
- 1492US10870657B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2019·Granted Dec 22, 2020·4 cites·7 claims
- 1592US6953790B2CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Oct 11, 2005·36 cites·22 claims
- 1692US6387903B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2000·Granted May 14, 2002·34 cites·12 claims
- 1792US5710171ABisphenyl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted Jan 20, 1998·131 cites·26 claims
- 1891US7491713B2CGRP receptor antagonistsMERCK & CO INC·Filed 2005·Granted Feb 17, 2009·11 cites·12 claims
- 1990US11026930B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2020·Granted Jun 8, 2021·2 cites·16 claims
- 2090US8039460B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Oct 18, 2011·19 cites·11 claims
- 2190US5534537AProdrugs of inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1995·Granted Jul 9, 1996·61 cites·17 claims
- 2289US5736539AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1994·Granted Apr 7, 1998·39 cites·19 claims
- 2388US10588894B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2018·Granted Mar 17, 2020·4 cites·6 claims
- 2488US10221191B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2016·Granted Mar 5, 2019·5 cites·5 claims
- 2588US5859012AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·84 cites·14 claims
- 2687US7476665B2Benzodiazepine CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Jan 13, 2009·30 cites·13 claims
- 2787US7205293B2Benodiazepine spirohydantoin CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Apr 17, 2007·28 cites·13 claims
- 2887US2025122216A1Compounds for the Treatment of Cancer and Inflammatory DiseaseSHY Therapeutics LLC·Filed 2024·Application pending·0 cites
- 2986US10940139B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 9, 2021·3 cites·27 claims
- 3086US7192954B2Monocyclic anilide spirohydantoin CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Mar 20, 2007·29 cites·17 claims
- 3185US11000515B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted May 11, 2021·2 cites·58 claims
- 3285US5631280AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1995·Granted May 20, 1997·69 cites·30 claims
- 3384US10933054B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 2, 2021·2 cites·30 claims
- 3484US5780492AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jul 14, 1998·35 cites·26 claims
- 3583US6610722B2Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted Aug 26, 2003·14 cites·16 claims
- 3681US2023149369A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 3780US5859015AN-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·49 cites·13 claims
- 3879US7205292B2CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Apr 17, 2007·9 cites·22 claims
- 3978US12391705B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Aug 19, 2025·1 cites·27 claims
- 4078US11541041B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 3, 2023·0 cites·39 claims
- 4177US7196079B2Benzodiazepine CGRP receptor antagonistsMERCK & CO INC·Filed 2004·Granted Mar 27, 2007·10 cites·16 claims
- 4277US6001835AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Dec 14, 1999·22 cites·29 claims
- 4376US11213515B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 4, 2022·0 cites·33 claims
- 4476US7659264B2CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Feb 9, 2010·3 cites·7 claims
- 4573US11560390B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2020·Granted Jan 24, 2023·0 cites·5 claims
- 4673US6380228B1Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted Apr 30, 2002·6 cites·22 claims
- 4772US6534506B2Inhibitors of prenyl-protein transferaseMERCK & CO INC·Filed 2001·Granted Mar 18, 2003·6 cites·17 claims
- 4872US5972984AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Oct 26, 1999·17 cites·22 claims
- 4972US5204328APeptides having atrial natriuretic factor activityMERCK & CO INC·Filed 1991·Granted Apr 20, 1993·30 cites·13 claims
- 5071US12459951B2Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2024·Granted Nov 4, 2025·0 cites·46 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Theresa M. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →